- Title
- Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls
- Creator
- Thompson, Ella R.; Gorringe, Kylie L.; Lupat, Richard; Delatycki, Martin B.; LifePool Investigators,; Mitchell , Gillian; James , Paul A.; Scott, Rodney J.; Campbell, Ian G.; Rowley, Simone M.; Wong-Brown, Michelle W.; McInerny, Simone; Li, Na; Trainer, Alison H.; Devereux, Lisa; Doyle, Maria A.; Li, Jason
- Relation
- Breast Cancer Research Vol. 17
- Publisher Link
- http://dx.doi.org/10.1186/s13058-015-0627-7
- Publisher
- BioMed Central
- Resource Type
- journal article
- Date
- 2015
- Description
- Introduction: PALB2 is emerging as a high-penetrance breast cancer predisposition gene in the order of BRCA1 and BRCA2. However, large studies that have evaluated the full gene rather than just the most common variants in both cases and controls are required before all truncating variants can be included in familial breast cancer variant testing. Methods: In this study we analyse almost 2000 breast cancer cases sourced from individuals referred to familial cancer clinics, thus representing typical cases presenting in clinical practice. These cases were compared to a similar number of population-based cancer-free controls. Results: We identified a significant excess of truncating variants in cases (1.3 %) versus controls (0.2 %), including six novel variants (p = 0.0001; odds ratio (OR) 6.58, 95 % confidence interval (CI) 2.3–18.9). Three of the four control individuals carrying truncating variants had at least one relative with breast cancer. There was no excess of missense variants in cases overall, but the common c.1676A > G variant (rs152451) was significantly enriched in cases and may represent a low-penetrance polymorphism (p = 0.002; OR 1.24 (95 % CI 1.09–1.47). Conclusions: Our findings support truncating variants in PALB2 as high-penetrance breast cancer susceptibility alleles, and suggest that a common missense variant may also lead to a low level of increased breast cancer risk.
- Subject
- PALB2 mutations; breast cancer; BRCA1; mutation analysis; women
- Identifier
- http://hdl.handle.net/1959.13/1334773
- Identifier
- uon:27356
- Identifier
- ISSN:1465-542X
- Rights
- © 2015 Thompson et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Language
- eng
- Full Text
- Reviewed
- Hits: 30453
- Visitors: 16155
- Downloads: 435
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 467 KB | Adobe Acrobat PDF | View Details Download |